This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Lung transplantation in cryptogenic fibrosing alveolitis

Authoring team

Lung transplantation should be discussed as a treatment option for people with idiopathic pulmonary fibrosis who do not have absolute contraindications

  • discussions should:
    • take place between 3 and 6 months after diagnosis or sooner if clinically indicated
    • be supported by an interstitial lung disease specialist nurse
    • include the risks and benefits of lung transplantation
    • involve the person's family and carers with the person's consent

  • people should be referred for lung transplantation assessment if they wish to explore lung transplantation and if there are no absolute contraindications. The transplant centre should be asked for an initial response within 4 weeks

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.